What is the Spravato success rate for treatment-resistant depression?
September 15, 2025
For individuals with major depressive disorder, the journey toward relief often involves trying several different antidepressants. When two or more of these treatments fail to provide meaningful improvement, the path forward can seem unclear and discouraging.
This clinical reality is known as treatment-resistant depression, a condition that requires a more specialized approach.
Spravato (esketamine) nasal spray offers a fundamentally different option, specifically designed to address this exact challenge. As an FDA-approved treatment, it works differently from traditional medications, often creating rapid changes and new neural pathways in the brain chemistry. The Spravato success rate shown in clinical trials is a key measure of its effectiveness, showing that many people experience significant symptom reduction.
This article explains how Spravato works against depressive symptoms, who qualifies for treatment, and what to expect during each session. We will cover how to navigate insurance coverage and share practical ways to support your progress. Understanding these details helps make the path to feeling better clearer, simpler, and more hopeful.
Key takeaways
- Spravato is the only FDA-approved ketamine nasal spray for adults with treatment-resistant depression who haven’t responded to at least two other oral antidepressants.
- Unlike serotonin-targeting medications, Spravato blocks NMDA receptors to rapidly rebuild neural connections, often showing results in days rather than weeks.
- Because it is FDA-approved and proven safe in clinical trials, most insurance plans cover the Spravato/ esketamine nasal spray with prior authorization. This helps make treatment affordable through standard copayments.
- Most often, the success of this treatment for depression requires following the twice-weekly initial treatment plan, communicating openly with providers, and combining with therapy when recommended.
- Marpa Minds offers Spravato in a spa-like setting with medical supervision and handles all insurance paperwork for a seamless healing experience.
What is Spravato for treatment-resistant depression?
Spravato is an FDA-approved nasal spray containing esketamine that helps people with treatment-resistant depression find relief. This means it’s designed for adults who’ve tried at least two different antidepressants without getting meaningful results.
You might wonder why Spravato works when other medications haven’t helped. The answer lies in how it affects your brain — instead of targeting serotonin like most antidepressants, Spravato blocks NMDA receptors to create rapid changes in brain chemistry.
The treatment happens in certified clinical settings where trained medical professionals supervise each session. This helps ensure both the efficiency of the treatment and the minimization of any adverse reactions. You’ll receive the nasal spray during scheduled appointments and stay for observation to ensure your safety and comfort.
Here’s what makes Spravato unique for treating depression:
- FDA-approved specifically for treatment-resistant cases: The only ketamine-based treatment with this designation
- Insurance coverage available: Most major plans cover it with prior authorization
- Rapid action possible: Many patients notice improvements within days rather than weeks
How does Spravato work in the brain?
Spravato contains esketamine, which blocks NMDA receptors/ glutamate receptors in your brain. This blocking action helps create new brain plasticity and create new neural connections to replace the ones depression has weakened or damaged.
Think of your brain as a communication network. Depression disrupts these brain cell communication pathways, making it harder for different parts of your brain to work together effectively. Spravato helps rebuild these connections, which can improve a host of aspects of your life, from cognitive performance to social functioning.
The medication triggers your brain to release growth factors that strengthen existing neural pathways and create new ones. This process happens much faster than with traditional antidepressants.
Your brain’s primary neurotransmitter, glutamate, plays a key role in this process. Spravato influences glutamate activity directly, which explains why you might feel improvements sooner than with medications that work through serotonin.
Wondering if Spravato can work for you? Read more on our blog:
- Does Spravato help with depression?
- Does Spravato help with anxiety?
- How long does Spravato last?
- What do you do during Spravato treatment?
- Can Spravato be taken at home?
- How does Spravato make you feel?
Spravato success rates and effectiveness data
Most often, success with Spravato is defined by experiencing at least a 50% reduction in your depression symptoms. Many patients achieve this level of improvement, with some reaching full remission rates, where symptoms become minimal.
Response rates vary between individuals, but clinical evidence shows meaningful improvements for many people with treatment-resistant depression. Your healthcare team will use standardized depression scales to track your progress objectively.
More specifically, Spravato (esketamine nasal spray) has shown significant success in clinical studies for treating treatment-resistant depression (TRD). Clinical data indicate remission rates between approximately 37% and 46%, with response rates around 48% to 60% after the first month of treatment. Real-world evidence shows that about 56.2% of patients achieve clinical response and 43.8% reach remission by month 3.
The treatment schedule starts with twice-weekly sessions for the first month. After this initial phase, you’ll transition to weekly or less frequent maintenance treatments based on your response.
Marpa Minds monitors each patient’s progress using validated assessment tools that measure the severity of the depression symptoms. This careful tracking helps ensure you’re getting the maximum benefit from your treatment.
For example, here are some key success indicators your care team will monitor during your treatment with the esketamine nasal spray:
- Symptom reduction: Measured using standardized depression rating scales
- Functional improvement: Your ability to engage in daily activities and relationships
- Sustained benefits: How well improvements maintain over time with continued treatment
Who makes Spravato and why the manufacturer matters
Janssen Pharmaceuticals, part of Johnson & Johnson, manufactures Spravato. This matters because you’re getting medication from an established pharmaceutical company with strict quality controls.
The company’s resources ensure consistent product quality and reliable supply. You won’t face treatment interruptions due to manufacturing issues or shortages.
Johnson & Johnson’s involvement also means ongoing research continues. The company invests in understanding how to optimize treatment protocols and identify which patients benefit most.
Who qualifies as an ideal candidate for Spravato?
You might be an ideal candidate if you’re an adult with major depressive disorder who hasn’t found relief from at least two antidepressants. Having tried multiple medications doesn’t mean you’ve failed — it means you’re appropriate for this specialized treatment.
Your doctor will confirm that you meet specific criteria. This includes being 18 or older, having a documented diagnosis of major depressive disorder, and trying previous antidepressants at adequate doses for a sufficient time.
Many people with co-occurring conditions like anxiety or PTSD also benefit from Spravato. Your overall health profile matters too, as your care team will check that you can safely receive the treatment.
Marpa Minds helps determine your eligibility through a comprehensive evaluation. The assessment focuses on matching you with the most appropriate treatment option.
7 ways to maximize Spravato treatment success
Your active participation significantly influences how well Spravato works for you. These strategies help create the best conditions for improvement and lasting results.
1. Follow the complete treatment protocol.
Attend every scheduled session without skipping. Each treatment builds on the previous one, creating cumulative benefits that develop over time, and help your brain find new ways to fight depressive symptoms.
2. Maintain open communication with your care team
Tell your providers about any side effects or concerns immediately. This information helps them adjust your treatment for optimal results and comfort.
3. Track your mood and symptoms consistently
Use a journal or mood tracking app daily. Recording changes helps you and your providers recognize improvements and make informed decisions about your care.
4. Combine treatment with therapy when recommended
Participate in psychotherapy if your team suggests it. The combination of Spravato and therapy often produces more comprehensive results than either approach alone.
5. Create a supportive treatment day routine
Arrange reliable transportation since you can’t drive after treatment. Plan for rest and create a calm environment at home for your recovery time.
6. Stay committed to the full treatment course
Complete all recommended sessions even if progress feels slow initially. Benefits often accumulate gradually, and stopping early may limit your improvement
7. Focus on gradual progress rather than immediate perfection
Celebrate small improvements in mood, energy, or daily functioning. Recovery typically involves steady progress rather than dramatic overnight changes.
How quickly do patients notice Spravato results?
You might notice initial improvements within hours or days of your first session. This rapid response sets Spravato apart from traditional antidepressants that typically take weeks to work.
Some people experience subtle mood lifts immediately. Others need several sessions before recognizing changes. Both patterns are normal and don’t predict your ultimate success.
The twice-weekly schedule during your first month helps build on these early improvements. Each session contributes to cumulative benefits that become more apparent over time.
Common early signs of improvement include:
- Sleep quality: Many notice improved sleep patterns within the first week
- Energy levels: Increased motivation and less fatigue often appear early
- Thought patterns: Reduced negative thinking and rumination
- Daily functioning: Easier completion of routine tasks and activities
Understanding Spravato treatment experience and safety
Your Spravato session begins with self-administering the nasal spray under medical supervision. You’ll then relax in a comfortable setting for about two hours while staff monitor your response.
Common side effects include mild dizziness or a feeling of detachment. These effects are temporary and typically resolve before you leave the facility.
The supervised environment ensures your safety throughout the process. Medical staff check your vital signs and comfort level regularly during the observation period.
Marpa Minds provides a spa-like atmosphere that feels more like a wellness center than a medical facility. This calming environment supports your healing while maintaining necessary safety protocols.
What to expect during your treatment session:
- Arrival and preparation: Brief vital sign check and medication administration
- Observation period: Two hours of monitored rest in a comfortable setting
- Recovery assessment: Evaluation before discharge to ensure you’re stable
- Transportation home: Arranged ride since driving isn’t permitted after treatment
Insurance coverage and accessibility for Spravato
Most major insurance plans cover Spravato because it’s FDA-approved for treatment-resistant depression. Coverage typically requires prior authorization, which is a standard insurance process.
Your healthcare provider submits documentation showing you’ve tried other antidepressants without success. This paperwork usually takes 1-2 weeks to process.
Once approved, you’ll pay standard copayments or work toward your deductible, similar to other specialty medications. Insurance coverage makes this treatment accessible without overwhelming costs.
Marpa Minds handles the entire insurance process for you. The team submits paperwork, follows up on approvals, and explains your coverage clearly.
Comparing Spravato to other ketamine treatments
Spravato offers distinct advantages over other ketamine options through FDA approval and standardized protocols. While IV ketamine exists, it lacks specific approval for depression and usually requires out-of-pocket payment.
The nasal spray format provides consistent, measured doses every time. IV treatments can vary in strength and protocol between different providers.
| Factor | Spravato | IV Ketamine |
|---|---|---|
| FDA approval for depression | Yes | No |
| Insurance coverage | Usually covered | Rarely covered |
| Dosing consistency | Standardized | Variable |
| Treatment setting | Certified facilities only | Various clinics |
| Safety monitoring | Required protocols | Varies by provider |
Getting started with Spravato treatment at Marpa Minds
Marpa Minds specializes in Spravato treatment within a serene, supportive environment designed for healing. The experienced team guides you through every step from evaluation to ongoing care.
Your journey begins with a thorough assessment to determine if Spravato matches your needs. The team handles all insurance details, removing administrative stress from your treatment process.
The spa-like treatment spaces help you feel relaxed and comfortable during each session. This environment, combined with expert care, creates optimal conditions for your recovery.
Take the first step by scheduling a consultation to discuss your treatment history and goals. The team will explain everything clearly and help you make an informed decision about moving forward.
Frequently asked questions
How long does a typical course of Spravato treatment last?
A typical Spravato treatment course starts with twice-weekly sessions for four weeks, followed by weekly sessions for another month. After this initial phase, many patients continue with maintenance treatments every 1-2 weeks based on their individual response and needs.
What should I expect if Spravato doesn’t provide enough relief for my depression?
If Spravato doesn’t provide adequate relief, your healthcare team will work with you to explore additional treatment options or adjustments. This might include combining Spravato with other therapies, adjusting the treatment schedule, or considering alternative approaches for treatment-resistant depression.
Can I return to work the same day after receiving Spravato treatment?
You cannot return to work immediately after Spravato treatment due to temporary side effects that affect alertness and coordination. Most patients need the remainder of the day to rest and recover, planning to return to normal activities the following day.
Does Spravato help with depression-related anxiety symptoms?
While Spravato is specifically approved for treatment-resistant depression, many patients report improvements in anxiety symptoms that often accompany depression. Your provider will evaluate whether Spravato is appropriate for your specific symptom profile during your consultation.
What are the out-of-pocket costs for Spravato with insurance coverage?
Out-of-pocket costs for Spravato vary by insurance plan but typically involve standard copayments or coinsurance for specialty medications. Many patients pay between $10-100 per session depending on their specific plan benefits and whether they’ve met their deductible.
How is Spravato different from the antidepressants I’ve already tried?
Spravato works through a completely different brain mechanism than traditional antidepressants by targeting NMDA receptors instead of serotonin pathways. This different approach often helps patients who haven’t responded to conventional medications and typically produces faster results than standard antidepressants.
About Author
